or
forgot password
  • cancer clinical trials in memphis, TN

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    University of Tennessee Cancer Institute - Memphis
    Memphis, Tennessee 38104
    Melanoma (Skin)
    Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    Veterans Affairs Medical Center - Memphis
    Memphis, Tennessee 38104
    Colorectal Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    CCOP - Baptist Cancer Institute

    Trial Locations
    CCOP - Baptist Cancer Institute
    University of Tennessee, Memphis Cancer Center
    Prostate Cancer
    Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
    University of Tennessee, Memphis Cancer Center
    Memphis, Tennessee 38103
    Lymphoma
    Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
    Methodist Hospital-Central Unit
    Memphis, Tennessee 38104
    Breast Cancer
    Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
    Boston Cancer Group
    Memphis, Tennessee 38119
    Head and Neck Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Head and Neck Cancer
    Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Sarcoma
    Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Prostate Cancer
    Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
    CCOP - Baptist Cancer Institute

    Trial Locations
    CCOP - Baptist Cancer Institute
    University of Tennessee, Memphis Cancer Center
    Head and Neck Cancer
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    University of Tennessee, Memphis Cancer Center
    Memphis, Tennessee 38103
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    University of Tennessee, Memphis Cancer Center
    Memphis, Tennessee 38103
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Hormone Therapy in Treating Patients With Prostate Cancer
    University of Tennessee, Memphis Cancer Center

    Trial Locations
    University of Tennessee, Memphis Cancer Center
    Veterans Affairs Medical Center - Memphis
    Prostate Cancer, Sexual Dysfunction and Infertility
    Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
    Veterans Affairs Medical Center - Memphis
    Memphis, Tennessee 38104
    Leukemia
    Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Veterans Affairs Medical Center - Memphis
    Memphis, Tennessee 38104
    Bladder Cancer
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Melanoma (Skin), Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    University of Tennessee, Memphis Cancer Center
    Memphis, Tennessee 38103
    Bladder Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Sarcoma
    Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
    Boston Cancer Group

    Trial Locations
    Boston Cancer Group
    West Clinic, P.C.
    Leukemia
    Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
    Veterans Affairs Medical Center - Memphis
    Memphis, Tennessee 38104
    Leukemia
    STI571 in Treating Patients With Recurrent Leukemia
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia
    Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    West Clinic, P.C.

    Trial Locations
    West Clinic, P.C.
    Memphis Cancer Center
    Lung Cancer
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors
    Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group
    Memphis, Tennessee 38119
    Lung Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Brain and Central Nervous System Tumors
    Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    Saint Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    University of Tennessee, Memphis Cancer Center
    Memphis, Tennessee 38103
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    West Clinic, P.C.

    Trial Locations
    West Clinic, P.C.
    Memphis Cancer Center
    Colorectal Cancer
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Head and Neck Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Memphis Cancer Center

    Trial Locations
    Memphis Cancer Center
    West Clinic
    Colorectal Cancer
    BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
    Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group
    Memphis, Tennessee 38119
    Pancreatic Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
    Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group
    Memphis, Tennessee 38119
    Leukemia, Lymphoma
    S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
    University of Tennessee Cancer Institute at Methodist Central Hospital
    Memphis, Tennessee 38104
    Prostate Cancer
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    Veterans Affairs Medical Center - Memphis
    Memphis, Tennessee 38104
    Prostate Cancer
    Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer
    Mroz-Baier Breast Care Center
    Memphis, Tennessee 38119
    Breast Cancer
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Baptist Memorial Hospital - Memphis
    Memphis, Tennessee 38120
    Alzheimer Disease
    ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
    Boston Baskin Cancer Group
    Memphis, Tennessee 38104
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Boston Baskin Cancer Group, University Tennessee
    Memphis, Tennessee 38104
    Lymphoma
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)
    Boston Baskin Cancer Group
    Memphis, Tennessee 38104
    Myelodysplastic Syndrome